Variant  Gene  Risk Allele  Score _{vda}  Association Type  Original DB  Sentence supporting the association  PMID  PMID Year  

_{}

C  0.730  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

C  0.730  GeneticVariation  GWASCAT  Genomewide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and nonglioblastoma tumors.  28346443  2017 

_{}

0.730  GeneticVariation  BEFREE  Using the χ(2) test, we found that rs2297440 and rs6010620 in RTEL1 increased risk of GBM.  26156397  2015 

_{}

0.730  GeneticVariation  BEFREE  The opposite is true of RTEL (20q13) region polymorphisms, which are significantly associated with glioblastoma (rs2297440, OR = 0.56, P = 4.6 × 10(10)) but not oligodendroglial tumor.  21356187  2011 

_{}

0.730  GeneticVariation  BEFREE  We identified LIG4 rs7325927 and BTBD2 rs11670188 as predictors of STS in GBM and CCDC26 rs10464870 and rs891835, HMGA2 rs1563834, and RTEL1 rs2297440 as predictors of LTS.  20368557  2010 

_{}

T  0.710  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

G  0.710  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

G  0.710  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

T  0.710  GeneticVariation  GWASCAT  Genomewide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and nonglioblastoma tumors.  28346443  2017 

_{}

G  0.710  GeneticVariation  GWASCAT  Genomewide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and nonglioblastoma tumors.  28346443  2017 

_{}

G  0.710  GeneticVariation  GWASCAT  Genomewide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and nonglioblastoma tumors.  28346443  2017 

_{}

0.710  GeneticVariation  BEFREE  The minor alleles of rs2736100 and rs10069690 SNP's, located in intron 2 and the promotor regions, respectively, were associated with an increased risk of developing GBM (p = 0.004 and 0.001).  26143636  2015 

_{}

T  0.710  GeneticVariation  GWASCAT  After genotyping an additional 1,490 cases and 1,723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P=3.02 × 10(9)) and nonGBM at 10q25.2 (rs11196067, near VTI1A, P=4.32 × 10(8)), 11q23.2 (rs648044, near ZBTB16, P=6.26 × 10(11)), 12q21.2 (rs12230172, P=7.53 × 10(11)) and 15q24.2 (rs1801591, near ETFA, P=5.71 × 10(9)).  26424050  2015 

_{}

0.710  GeneticVariation  BEFREE  After genotyping an additional 1,490 cases and 1,723 controls we identify new risk loci for glioblastoma (GBM) at 12q23.33 (rs3851634, near POLR3B, P=3.02 × 10(9)) and nonGBM at 10q25.2 (rs11196067, near VTI1A, P=4.32 × 10(8)), 11q23.2 (rs648044, near ZBTB16, P=6.26 × 10(11)), 12q21.2 (rs12230172, P=7.53 × 10(11)) and 15q24.2 (rs1801591, near ETFA, P=5.71 × 10(9)).  26424050  2015 

_{}

0.710  GeneticVariation  BEFREE  Analysis by glioma subtype showed the association with rs55705857 confined to nonglioblastoma multiforme (nonGBM) tumours (P = 1.07 × 10(67)).  23399484  2013 

_{}

0.710  GeneticVariation  BEFREE  The association between rs78378222 and risk was seen for both glioblastoma multiforme (GBM) and nonGBM tumours.  23571737  2013 

_{}

A  0.700  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

G  0.700  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

A  0.700  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

G  0.700  GeneticVariation  GWASCAT  Agespecific genomewide association study in glioblastoma identifies increased proportion of 'lower grade glioma'like features associated with younger age.  30152087  2018 

_{}

C  0.700  GeneticVariation  GWASCAT  We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10<sup>9</sup>, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10<sup>10</sup>, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10<sup>8</sup>, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10<sup>11</sup>, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10<sup>10</sup>, OR = 1.15), as well as eight loci for nonGBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10<sup>9</sup>, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10<sup>10</sup>, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10<sup>10</sup>, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10<sup>9</sup>, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10<sup>8</sup>, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10<sup>10</sup>, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10<sup>11</sup>, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10<sup>9</sup>, OR = 1.18).  28346443  2017 

_{}

C  0.700  GeneticVariation  GWASCAT  We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10<sup>9</sup>, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10<sup>10</sup>, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10<sup>8</sup>, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10<sup>11</sup>, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10<sup>10</sup>, OR = 1.15), as well as eight loci for nonGBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10<sup>9</sup>, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10<sup>10</sup>, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10<sup>10</sup>, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10<sup>9</sup>, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10<sup>8</sup>, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10<sup>10</sup>, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10<sup>11</sup>, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10<sup>9</sup>, OR = 1.18).  28346443  2017 

_{}

T  0.700  GeneticVariation  GWASCAT  We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10<sup>9</sup>, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10<sup>10</sup>, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10<sup>8</sup>, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10<sup>11</sup>, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10<sup>10</sup>, OR = 1.15), as well as eight loci for nonGBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10<sup>9</sup>, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10<sup>10</sup>, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10<sup>10</sup>, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10<sup>9</sup>, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10<sup>8</sup>, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10<sup>10</sup>, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10<sup>11</sup>, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10<sup>9</sup>, OR = 1.18).  28346443  2017 

_{}

G  0.700  GeneticVariation  GWASCAT  We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10<sup>9</sup>, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10<sup>10</sup>, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10<sup>8</sup>, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10<sup>11</sup>, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10<sup>10</sup>, OR = 1.15), as well as eight loci for nonGBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10<sup>9</sup>, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10<sup>10</sup>, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10<sup>10</sup>, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10<sup>9</sup>, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10<sup>8</sup>, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10<sup>10</sup>, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10<sup>11</sup>, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10<sup>9</sup>, OR = 1.18).  28346443  2017 

_{}

T  0.700  GeneticVariation  GWASCAT  We identified five new loci for glioblastoma (GBM) at 1p31.3 (rs12752552; P = 2.04 × 10<sup>9</sup>, odds ratio (OR) = 1.22), 11q14.1 (rs11233250; P = 9.95 × 10<sup>10</sup>, OR = 1.24), 16p13.3 (rs2562152; P = 1.93 × 10<sup>8</sup>, OR = 1.21), 16q12.1 (rs10852606; P = 1.29 × 10<sup>11</sup>, OR = 1.18) and 22q13.1 (rs2235573; P = 1.76 × 10<sup>10</sup>, OR = 1.15), as well as eight loci for nonGBM tumors at 1q32.1 (rs4252707; P = 3.34 × 10<sup>9</sup>, OR = 1.19), 1q44 (rs12076373; P = 2.63 × 10<sup>10</sup>, OR = 1.23), 2q33.3 (rs7572263; P = 2.18 × 10<sup>10</sup>, OR = 1.20), 3p14.1 (rs11706832; P = 7.66 × 10<sup>9</sup>, OR = 1.15), 10q24.33 (rs11598018; P = 3.39 × 10<sup>8</sup>, OR = 1.14), 11q21 (rs7107785; P = 3.87 × 10<sup>10</sup>, OR = 1.16), 14q12 (rs10131032; P = 5.07 × 10<sup>11</sup>, OR = 1.33) and 16p13.3 (rs3751667; P = 2.61 × 10<sup>9</sup>, OR = 1.18).  28346443  2017 